A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
Successful Management Preventing Severe Bleeding during the Perioperative Period for Subdural Hematoma by Using Recombinant Activated Coagulation Factor VII in a Case of Acquired Hemophilia A
遺伝子組換え型活性型第VII因子製剤投与により慢性硬膜下血腫に対する穿頭血腫灌流除去術中の出血制御に成功した後天性血友病Aの1例
2016
The Kitakanto Medical Journal
遺伝子組換え型活性型第VII因子製剤投与により慢性硬膜下血腫に対する穿頭血腫灌流除去術中の出血制御に成功した後天性血友病Aの1例
Acquired hemophilia A (AHA) is a rare coagulation disorder caused by autoantibodies against coagulation factor VIII (FVIII). We report herein a case of AHA whose severe bleeding were successfully managed during the perioperative period of the surgery for chronic subdural hematoma by using recombinant activated factor VII (rFVIIa). A 54-y ear-old man was hospitalized due to cardioembolic MCA (middle cerebral artery)occlusion. He experienced severe and persistent urethral bleeding after urinary
doi:10.2974/kmj.66.211
fatcat:yxffcf764rbqxo46h6enyqglnm